Abstract
Transarterial radioembolization (TARE) with Yttrium-90 (90Y) microspheres is an increasingly prevalent intervention in the management of unresectable primary or metastatic liver malignancies. This procedure may be performed in a super selective manner, in which the radioactive microspheres are directly delivered to the diseased segment of liver while sparing nearby healthy tissue. As no widespread, standardized protocol for super selective TARE exists, it is imperative that institutions be transparent with treatment outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
